5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of the National Cancer Institute

• Publication date

  2005-10-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/DJI188PMID 16204693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New targets for pyrimidine antimetabolites in the treatment of solid tumours

  2005cited by this paper
• Treatment of colon and breast carcinoma cells with 5‐fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA‐A(*)02.01 restricted, CEA‐peptide‐specific cytotoxic T cells in vitro

  2003cited by this paper
• In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse

  2003cited by this paper
• High-Affinity HLA-A(*)02.01 Peptides from Parathyroid Hormone-Related Protein Generate In Vitro and In Vivo Antitumor CTL Response Without Autoimmune Side Effects1

  2002cited by this paper
• Distribution of Mutations in Human Thymidylate Synthase Yielding Resistance to 5-Fluorodeoxyuridine*

  2002cited by this paper
• Monitoring antigen-specific T cells using MHC-Ig dimers.

  2001cited by this paper
• In Vitro Generation of Cytotoxic T Lymphocytes Against HLA-A2.1 -Restricted Peptides Derived from Human Thymidylate Synthase

  2001cited by this paper
• O(6)-benzylguanine enhances the in vitro immunotoxic activity of temozolomide on natural or antigen-dependent immunity.

  1999cited by this paper
• MHC Ligands and Peptide Motifs

  1998cited by this paper
• United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).

  1998cited by this paper
• Random Sequence Mutagenesis and Resistance to 5-Fluorouridine in Human Thymidylate Synthases*

  1998cited by this paper
• Prognostic importance of thymidylate synthase expression in early breast cancer.

  1997cited by this paper
• HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice

  1997cited by this paper
• The role of thymidylate synthase as an RNA binding protein

  1996cited by this paper
• New targets for pyrimidine antimetabolites in the treatment of solid tumours

  1994cited by this paper
• Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

  1994cited by this paper
• Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes

  1993cited by this paper
• Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.

  1992cited by this paper
• Current protocols in immunology

  1991cited by this paper
• NK susceptibility varies inversely with target cell class I HLA antigen expression.

  1987cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• Cancer: Principles and Practice of Oncology

  1982cited by this paper
• A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field.

  1968cited by this paper

• Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?

  2021cites this paper
• AutologousDendritic Cell-Cytokine InducedKiller Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer : A Prospective Study

  2019cites this paper
• Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

  2018cites this paper
• Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine

  2018cites this paper
• Immunological monitoring for prediction of clinical response to antitumor vaccine therapy

  2018cites this paper
• Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study

  2017cites this paper
• Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study

  2017cites this paper
• Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients

  2016cites this paper
• Chemotherapy and immunotherapy: mapping the road ahead.

  2016cites this paper
• Immunotherapy of colorectal cancer: new perspectives after a long path.

  2016cites this paper
• Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model

  2016cites this paper
• Strategies to Improve the Efficacy of Vaccines by Selective Manipulation of the Immune System: A Translational Study

  2016cites this paper
• Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients

  2016cites this paper
• Enhancing the anticancer effects of 5-fluorouracil: Current challenges and future perspectives

  2015cites this paper
• Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients

  2015influential citation
• Chemoimmunotherapy: still waiting for the magic to happen.

  2014cites this paper
• Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Concepts

  2013cites this paper
• Effect of Chemotherapy on the Tumor Microenvironment and Anti-tumor Immunity

  2013cites this paper
• Monitoring immune responses in dendritic cell based vaccination with a focus on in vivo imaging

  2013cites this paper
• Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer.

  2013cites this paper
• The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro

  2013cites this paper
• Tumor Ablation

  2013cites this paper
• Cetuximab ± chemotherapy enhances dendritic cell‐mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen‐specific cytotoxic T‐cell response in vitro

  2012cites this paper
• Epitope Peptides Vaccine for Colorectal Cancer -the Present Status and the Prospects-

  2012cites this paper
• Recent advances in active specific cancer vaccine treatment for colorectal cancer.

  2012cites this paper
• Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients

  2012cites this paper
• Effect of three fluoride compounds on the growth of oral normal and tumor cells.

  2012cites this paper
• Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines

  2011cites this paper
• Analysis of tumor antigen‐specific T cells and antibodies in cancer patients treated with radiofrequency ablation

  2011cites this paper
• Immunotherapy combined with chemotherapy in the treatment of tumors.

  2010cites this paper
• Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer.

  2010cites this paper
• A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients

  2010cites this paper
• Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy

  2009cites this paper
• Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer

  2009influential citation
• Cytosine Deaminase-Uracil Phosphoribosyltransferase and Interleukin (IL)-12 and IL-18: A Multimodal Anticancer Interface Marked by Specific Modulation in Serum Cytokines

  2009cites this paper
• Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy

  2008cites this paper
• Chemotherapeutic Drugs may be Used to Enhance the Killing Efficacy of Human Tumor Antigen Peptide-specific CTLs

  2008cites this paper
• Immunological aspects of cancer chemotherapy

  2008cites this paper
• The anticancer immune response: indispensable for therapeutic success?

  2008cites this paper
• Dendritic cell vaccines in melanoma: from promise to proof?

  2008cites this paper
• Prognostic significance of thymidylate synthase expression in patients with prostate cancer undergoing radical prostatectomy.

  2007cites this paper
• Modification of the tumor microenvironment to enhance immunity.

  2007cites this paper
• Induction of multiple CD8+ T cell responses against the inducible Hsp70 employing an Hsp70 oligoepitope peptide.

  2007cites this paper
• Thymidylate synthase inhibitors.

  2006cites this paper
• Design of peptide-based vaccines for cancer.

  2006cites this paper
• Combined chemoimmunotherapy of solid tumours: improving vaccines?

  2006cites this paper
• Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience

  2006cites this paper
• Cytotoxins and cancer immunotherapy: the dance of the macabre?

  2005cites this paper
• Induction of multiple CD 8 + T cell responses against the inducible Hsp 70 employing an Hsp 70 oligoepitope peptide

  year unknowncites this paper